Cancer Protocols
In this video, Robert Bradford spends about 30 minutes speaking on "Cancer Protocols" at the 28th Annual Cancer Convention held on Labor Day weekend by the Cancer Control Society.
About Robert Bradford
ROBERT BRADFORD, D.Sc., is Founder and Professor of Medicine, Vice Chairman and Treasurer, Board of Trustees at Capital University of Integrative Medicine (CUIM) in Washington, D.C. In addition, he chairs the Department of Microbiology, Microscopy and Oxidology at CUIM. He serves as Director of Research for the Bradford Research Institute, American Biologics and the American Biologics Integrative Medical Center at its new location in Las Playas, De Tijuana, Mexico.
Dr. Bradford is also a Visiting Professor of Medicine to several hospitals and medical schools for the People's Republic of China. He holds a Doctorate in Science and Ph.D. in Biochemistry, Medicina Alternativa, Stockholm, and is a board-certified Naturopath in the states of Idaho and Washington, D.C.
As an innovative medical/biochemical pioneer and inventor whose research activities have resulted in international honors, major breakthroughs in science and the delineation of an entirely new medical discipline, "Oxidology," he holds numerous patents, i.e., the Bradford Variable Projection Microscope (BVPM®) in the U.S., Europe, Canada, Mexico, China and Taiwan. Additionally, Dr. Bradford researched and developed 2 pre-clinical peripheral blood assessments for identifying metabolic disorders and oxidative stress as biological probes for evaluating integrative therapies for chronic diseases and the Accelerated Change Normalization (ACN®) technology, a bioelectrical approach to cancer and other conditions modulating tissue potential.
A major leader in the American health movement, Dr. Bradford began his career in 1972 when he founded the Committee for Freedom of Choice in Medicine, a lobbying educational organization, which funded many court battles and eventually led to the decriminalization of Laetrile in 26 states in the U.S.
Transcription
Jesus, everybody hears me. This is fine.
First of all, before I get started, American Biologics puts on international symposiums around the world once a year. And I know how much work goes into putting some something like this together. And I think that Lorraine Rosenthal and all of her crew, to put something like this together that's growing every year, we ought to ought to give her a big hand, just for appreciation.
And first of all, I'm a Professor of Medicine at Capital University in Washington, D.C., which is the first post-graduate University of Integrative Medicine under the Department of Education in the United States.
And this December, we will have graduated our fifth class. We're not an undergraduate university, we are postgraduate. So the doctors who come and get a degree in Integrative Medicine already have their undergraduate degrees; the M.Ds, the D.O's, the chiropractors, the dentist, naturopathic physicians, and so forth.
American Biologics & Bradford Research Institute
Secondly, I'm the founder of American Biologics, and we're almost 25 years now. I'm the director of the Bradford Research Institute. We have hospitals around the world, we have one in Mexico, I have 5 associated Bradford clinics in Taiwan. I have two in mainland China, we have a number of associations throughout Europe and so forth. And the reason why we're spread out this way is that we're very interested in not only what's going on in the United States, but what's going on worldwide, what's going on in degenerative diseases in general, and in this particular case, cancer specifically.
So in the very short period of time that I have, I want to share with you some of the research that's been going on with the Bradford Research Institute in the last year since the last time I spoke here. First of all, we have to understand some of the basic phenomenons involved in malignant processes themselves. And one of those has to do with phenomena that they call redox potential. That is to say, in this particular case, the cancer cell is in a very reduced state.
What does that really mean? What it means is that there's a heavy electron concentration. If we talk about an oxidative state, we're talking about the loss of electrons. If we talk about a reduced state, we talk about the accumulation of electrons. And what it really means in this particular case, it has a pronounced effect on how the biological system can address malignant tissue.
And in this particular case where you have a highly negative tissue potential, it essentially repels the immune system. One of the reasons why for instance, we have relatively poor effects in breast cancer